Alnylam Pharmaceuticals
Sandeep Menon currently serves as the Chief Development Officer and Head of Clinical Development and Safety at Alnylam Pharmaceuticals since November 2023. Sandeep also holds positions as an Adjunct Assistant Professor at Tufts University School of Medicine, Adjunct Faculty at the Indian Institute of Management, and Adjunct Professor at Boston University School of Public Health, all since 2014 or 2010. Prior to joining Alnylam Pharmaceuticals, Sandeep accumulated extensive experience at Pfizer from June 2010 to December 2023 in various roles, including Chief Scientific Officer, Senior Vice President of Early Clinical Development, and Director of Clinical Development and Biostatistics. Additional experience includes roles at Biogen Idec, Averion International, and Harvard Clinical Research Institute, as well as a background as a Family Physician and Consulting Physician. Sandeep's educational qualifications include a PhD in Biostatistics and Master's degrees in Public Health and Translational Pharmacology from Boston University and The Ohio State University, respectively, along with a Bachelor's degree in Hom. Medicine and Surgery from Karnataka University.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
31 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.